Tag - daiichi-sankyo

 
 

DAIICHI SANKYO

Japan Times
BUSINESS / Companies
Feb 9, 2015
Growth concerns loom for Daiichi Sankyo on drug warning
Daiichi Sankyo Co. risks losing a slice of revenue to generic-medicine competition next year. Now, the drugmaker's plans to fill the gap have hit a roadblock and investors worry that growth may flounder.
Japan Times
BUSINESS / Companies
Sep 29, 2014
Daiichi Sankyo to buy Ambit to strengthen cancer product line
Daiichi Sankyo Co. has agreed to buy U.S.-based Ambit Biosciences Corp. for as much as $410 million to bolster its pipeline of cancer treatments.

Longform

Sociologist Gracia Liu-Farrer argues that even though immigration doesn't figure into Japan's autobiography, it is more of a self-perception than a reality.
In search of the ‘Japanese dream’